Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Shinozuka, H.
Right arrow Articles by Abanobi, S. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shinozuka, H.
Right arrow Articles by Abanobi, S. E.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1982 Oxford University Press

research-article

A comparative study of the efficacy of four barbiturates as promoters of the development of {gamma}-glutamyltranspeptidase-positive foci in the liver of carcinogen treated rats

Hisashi Shinozuka, Benito Lombardi and Samuel E. Abanobi

Department of Pathology, University of Pittsburgh, School of Medicine Pittsburgh, PA 15261, USA.

The promoting action of four barbiturates, and their modulation of the promoting action of a choline-devoide (CD) diet was investigated by quantitating the {gamma}-glutamyitranspeptidase (GGT)-positive foci which developed in the liver of rats exposed to a single injection of diethylnitrosamine. Phenobarbital (PHB), pentobarbital (PTB) and amobarbital (AMB), exerted a promoting action, while barbituric acid (BA) had no effect. Addition of PHB or PTB to a CD diet resulted in a synergistic promoting action, but AMB had only an additive effect. Feeding a CD diet to rats caused a stimulation of liver DNA synthesis and of cell proliferation. These effects of the diet were markedly inhibited by addition of PHB or PTB, while addition of AMB resulted only in an inhibition of the enhanced proliferation of hepatocytes. No inhibitory effect was exerted by BA. The results indicate that the liver tumor promoting action of PHB and of barbiturates is dependent upon biological effects related to the presence of an alkyl group in their side chain. It is hypothesized that the promoting action of the agents herein studied may involve two components, a stimulation of the proliferaton of initiated liver cells, and a suppression of the proliferation of non-initiated cells.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Toxicol PatholHome page
T. Shoda, K. Mitsumori, H. Onodera, K. Toyoda, C. Uneyama, K. Takada, and M. Hirose
Live Tumor-Promoting Effect of {beta}-Naphthoflavone, a Strong CYP 1A1/2 Inducer, and the Relationship between CYP 1A1/2 Induction and Cx32 Decrease in Its Hepatocarcinogenesis in the Rat
Toxicol Pathol, July 1, 2000; 28(4): 540 - 547.
[Abstract] [PDF]


Home page
Toxicol PatholHome page
T. Shoda, H. Onodera, M. Takeda, C. Uneyama, T. Imazawa, K. Takegawa, K. Yasuhara, T. Watanabe, M. Hirose, and K. Mitsumori
Liver Tumor Promoting Effects of Fenbendazole in Rats
Toxicol Pathol, September 1, 1999; 27(5): 553 - 562.
[Abstract] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. S. Sidhu and C. J. Omiecinski
An Okadaic Acid-Sensitive Pathway Involved in the Phenobarbital-Mediated Induction of CYP2B Gene Expression in Primary Rat Hepatocyte Cultures
J. Pharmacol. Exp. Ther., August 1, 1997; 282(2): 1122 - 1129.
[Abstract] [Full Text]


Home page
Toxicol PatholHome page
M. I. R. Perera, J. M. Betschart, M. A. Virji, S. L. Katyal, and H. Shinozuka
Free Radical Injury and Liver Tumor Promotion
Toxicol Pathol, January 1, 1987; 15(1): 51 - 59.
[Abstract] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.